Rapid exome sequencing in PICU patients with new-onset metabolic or neurological disorders

被引:17
|
作者
Carey, Abigail S. [1 ,2 ,3 ]
Schacht, John P. [2 ,3 ,4 ]
Umandap, Christine [2 ,3 ,4 ]
Fasel, David [3 ,5 ]
Weng, Chunhua [3 ,5 ]
Cappell, Joshua [1 ,2 ,3 ]
Chung, Wendy K. [2 ,3 ,4 ]
Kernie, Steven G. [1 ,2 ,3 ]
机构
[1] Columbia Univ, Div Pediat Crit Care Med, New York, NY 10027 USA
[2] Columbia Univ, Dept Pediat, New York, NY 10027 USA
[3] Columbia Univ, NewYork Presbyterian Morgan Stanley Childrens Hos, Vagelos Coll Phys & Surg, New York, NY 10027 USA
[4] Columbia Univ, Div Mol Genet, New York, NY USA
[5] Columbia Univ, Dept Biomed Informat, New York, NY USA
基金
美国国家卫生研究院;
关键词
CLINICAL EXOME; RECOMMENDATIONS; STATEMENT; DISEASES; INFANTS;
D O I
10.1038/s41390-020-0858-x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background Genomic assessment previously took months to result and was unable to impact clinical care in the pediatric intensive care unit (PICU). The advent of rapid exome sequencing potentially changes this. We investigated the impact of rapid exome sequencing in a pilot study on pediatric patients admitted to a single PICU with new-onset metabolic/neurologic disease. Methods Rapid exome sequencing (7 days to verbal result) was performed on (n = 10) PICU patients age < 6 years admitted with new-onset metabolic/neurologic disease. The primary outcome of interest was inpatient LOS, which served as a proxy for inpatient cost. Results A significant reduction in median LOS was identified when comparing PICU patients who underwent rapid exome sequencing to historical controls. From those patients who underwent rapid sequencing, five had likely pathogenic variants. In three cases with diagnostic genetic results, there was a modification to clinical care attributable to information provided by exome sequencing. Conclusions This pilot study demonstrates that rapid exome sequencing is feasible to do in the PICU, that genetic results can be returned quickly enough to impact critical care decision-making and management. In a select population of PICU patients, this technology may contribute to a decrease in hospital length of stay. Impact Ten prospectively enrolled PICU patients with defined clinical criteria and their parents underwent rapid exome sequencing. Fifty percent received a genetic diagnosis, and medical management was affected for 60% of those patients. Median hospital LOS was significantly decreased in this selective subset of PICU patients. Genetic disorders and congenital anomalies are a leading cause of pediatric mortality. Genomic assessment previously took weeks to months for results and was therefore unable to acutely impact clinical care in the pediatric intensive care unit (PICU). The recent advent of rapid exome sequencing changes this in selected patients. Rapid exome sequencing is feasible to do in a PICU. Genetic results can be returned quickly enough to impact critical care decision-making. When done in a carefully selected subset of pediatric patients, rapid exome sequencing can potentially decrease hospital LOS.
引用
收藏
页码:761 / 768
页数:8
相关论文
共 50 条
  • [1] Rapid exome sequencing in PICU patients with new-onset metabolic or neurological disorders
    Abigail S. Carey
    John P. Schacht
    Christine Umandap
    David Fasel
    Chunhua Weng
    Joshua Cappell
    Wendy K. Chung
    Steven G. Kernie
    Pediatric Research, 2020, 88 : 761 - 768
  • [2] Exome sequencing for neurological disorders
    Vance, J.
    Tekin, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 21 - 21
  • [3] Evaluation of genetic variants in new-onset hidradenitis suppurativa patients by exome sequencing
    Posch, C.
    Ahn, R.
    Wiala, A.
    Rappersberger, K.
    Liao, W.
    EXPERIMENTAL DERMATOLOGY, 2019, 28 (03) : E43 - E43
  • [4] Impact of new-onset and preexisting neurological disorders in COVID-19 patients
    Lindemann, Sarah
    Boehm, Markus
    Gonnert, Falk
    Boesel, Julian
    Schubert, Roger
    Musleh, Rita
    Guenther, Albrecht
    BRAIN AND BEHAVIOR, 2023, 13 (07):
  • [5] Clinical Application of Whole Exome Sequencing for Monogenic Disorders in PICU of China
    Liu, Yingchao
    Hao, Chanjuan
    Li, Kechun
    Hu, Xuyun
    Gao, Hengmiao
    Zeng, Jiansheng
    Guo, Ruolan
    Liu, Jun
    Guo, Jun
    Li, Zheng
    Qi, Zhan
    Jia, Xinlei
    Li, Wei
    Qian, Suyun
    FRONTIERS IN GENETICS, 2021, 12
  • [6] Rapid exome sequencing for children with acute cardiomyopathy in the PICU - a case series
    Hershkovitz, Tova
    Habib, Clair
    Paperna, Tamar
    Zaid, Rinat
    Ben Ari, Josef
    Tal, Galit
    Khoury, Asaad
    Weiss, Karin
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 150 - 150
  • [7] Diagnostic Exome Sequencing in Adolescents with Neurological and Neurodevelopmental Disorders
    Blanco, Kirsten
    Powis, Zoe
    Hagman, Kelly D. F.
    Weltmer, Elaine C.
    Tang, Sha
    NEUROLOGY, 2018, 90
  • [8] Implementation of Exome Sequencing in Clinical Practice for Neurological Disorders
    Isabel Alvarez-Mora, Maria
    Rodriguez-Revenga, Laia
    Jodar, Meritxell
    Potrony, Miriam
    Sanchez, Aurora
    Badenas, Celia
    Oriola, Josep
    Villanueva-Canas, Jose Luis
    Munoz, Esteban
    Valldeoriola, Francesc
    Camara, Ana
    Compta, Yaroslau
    Carreno, Mar
    Jose Marti, Maria
    Sanchez-Valle, Raquel
    Madrigal, Irene
    GENES, 2023, 14 (04)
  • [9] Effectiveness of clinical exome sequencing in adult patients with difficult-to-diagnose neurological disorders
    Sainio, Markus T.
    Aaltio, Juho
    Hyttinen, Virva
    Kortelainen, Mika
    Ojanen, Simo
    Paetau, Anders
    Tienari, Pentti
    Ylikallio, Emil
    Auranen, Mari
    Tyynismaa, Henna
    ACTA NEUROLOGICA SCANDINAVICA, 2022, 145 (01): : 63 - 72
  • [10] Application of whole exome sequencing to study a cohort of Greek patients with heterogeneous neurological disorders
    Latsoudis, H.
    Vogiatzi, E.
    Evangeliou, A.
    Mastorodemos, V.
    Kotzamani, D.
    Monti, K.
    Zafeiriou, D.
    Amoiridis, G.
    Plaitakis, A.
    Zaganas, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 166 - 166